Table 4.
Original studies referred to in relation to suspicion criteria in the form of imaging findings and cardiac biomarkers
| Imaging technique/biomarker | Study type | ||
|---|---|---|---|
| Prospective | Descriptive | Comparative | |
| ECG | Applicability of ECG and ECHO in diagnosing CA, not specifically ATTRwt CM 86 | Description of ATTRwt CM in specific 3 |
Comparison of ECG in different types of CA 79 , 87 , 88 , 89 , 90 Comparison between CA and other diseases 91 |
| Echocardiography | Description of ATTRwt CM in specific 3 |
Comparison of ECHO in different types of CA 88 , 92 , 93 , 94 , 95 Comparison between CA and other diseases or controls 96 , 97 , 98 , 99 , 100 |
|
| CMR |
Comparison of CMR between CA and other cardiac diseases 101 , 102 , 103 , 104 , 105 Comparison of CMR between different types of CA 106 , 107 , 108 , 109 |
||
| Cardiac biomarkers | Comparison of high‐sensitivity cardiac troponin T levels between CA and other causes of cardiac hypertrophy 110 | ||
ATTRwt CM, wild‐type transthyretin amyloid cardiomyopathy; CA, cardiac amyloidosis; CMR, cardiac magnetic resonance; ECG, electrocardiography; ECHO, echocardiography.